- Report
- July 2024
- 158 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- April 2025
- 37 Pages
Global
From €1345EUR$1,583USD£1,193GBP
- Report
- April 2025
Global
From €3595EUR$3,950USD£3,082GBP
- Conference
- October 2025
- 2 Days
Global
€1568EUR$1,784USD£1,299GBP
€1810EUR$2,058USD£1,499GBP
- Conference
- November 2025
- 2 Days
Global
€1568EUR$1,784USD£1,299GBP
€1810EUR$2,058USD£1,499GBP
- Conference
- October 2025
- 2 Days
Global
€1206EUR$1,372USD£999GBP
€1448EUR$1,646USD£1,199GBP
- Conference
- July 2025
- 2 Days
Global
€1568EUR$1,784USD£1,299GBP
€1810EUR$2,058USD£1,499GBP
- Conference
- June 2025
- 2 Days
Global
€1206EUR$1,372USD£999GBP
€1448EUR$1,646USD£1,199GBP
- Report
- April 2025
- 387 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2025
- 130 Pages
Global
From €3973EUR$4,365USD£3,406GBP
€4414EUR$4,850USD£3,784GBP
- Training
- February 2025
- 2 Days
Global
From €1453EUR$1,597USD£1,246GBP
- Report
- February 2025
- 132 Pages
Global
From €3973EUR$4,365USD£3,406GBP
€4414EUR$4,850USD£3,784GBP
- Report
- February 2025
- 227 Pages
Global
From €3686EUR$4,050USD£3,160GBP
- Report
- January 2025
- 600 Pages
Global
From €1274EUR$1,400USD£1,092GBP
- Report
- January 2025
- 182 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- January 2025
- 196 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- January 2025
- 388 Pages
Global
From €1836EUR$2,018USD£1,574GBP
€2448EUR$2,690USD£2,099GBP
- Report
- January 2025
- 209 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- January 2025
- 191 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Training
- December 2024
- 3 Days
Global
From €2121EUR$2,331USD£1,819GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more